Literature DB >> 17618043

Inflammation and chronic prostatic diseases: evidence for a link?

Alessandro Sciarra1, Franco Di Silverio, Stefano Salciccia, Ana Maria Autran Gomez, Alessandro Gentilucci, Vincenzo Gentile.   

Abstract

OBJECTIVES: Emerging evidence indicates that prostatic inflammation may contribute to prostate growth either in terms of hyperplastic (benign prostatic hyperplasia [BPH]) or neoplastic (prostate cancer [PCa]) changes. We propose two questions: Does prostate inflammation represent a significant factor for the development and the progression of both BPH and PCa? Are data available now to sustain the identification of prostate inflammation as a risk factor for prostate diseases?
METHODS: We reviewed the recent international literature using a PubMed search to analyze new findings supporting a role for inflammation in BPH and PCa growth and progression.
RESULTS: On histologic examinations from patients with BPH, inflammatory aspects are present in approximately 40% of cases. The men with inflammatory aspects inside the prostate have a significantly higher risk for BPH progression and acute urinary retention. Evidence shows that a cyclooxygenase-2 (COX-2) inhibitor can increase the apoptotic activity in human BPH tissue. Analyses on the bacterial colonization in PCa and normal prostate tissue showed a highly suggestive correlation between bacterial colonization/chronic inflammation and the diagnosis of PCa. Evidence from genetic studies supports the hypothesis that prostate inflammation may be a cause of PCa development. Proliferative inflammatory atrophy has been considered as an early histologic precursor to prostatic intraepithelial neoplasia and PCa.
CONCLUSION: The concept that inflammation can promote chronic prostatic diseases, such as BPH or PCa, is actually supported by several new significant findings; however, no specific oncologic surveillance for these cases is justified at the moment.

Entities:  

Mesh:

Year:  2007        PMID: 17618043     DOI: 10.1016/j.eururo.2007.06.038

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  52 in total

1.  Characterisation of the prostanoid receptor mediating inhibition of smooth muscle contractility in the rat prostate gland.

Authors:  Slavko Tokanovic; Carl W White; Daniel T Malone; Betty Exintaris; Sabatino Ventura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-02-24       Impact factor: 3.000

2.  Effects of Estrogen Receptor β Stimulation in a Rat Model of Non-Bacterial Prostatic Inflammation.

Authors:  Shinsuke Mizoguchi; Kenichi Mori; Zhou Wang; Teresa Liu; Yasuhito Funahashi; Fuminori Sato; Donald B DeFranco; Naoki Yoshimura; Hiromitsu Mimata
Journal:  Prostate       Date:  2017-02-09       Impact factor: 4.104

3.  Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.

Authors:  D Altavilla; L Minutoli; F Polito; N Irrera; S Arena; C Magno; M Rinaldi; B P Burnett; F Squadrito; A Bitto
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation.

Authors:  Xiaohai Wang; Wen-Jye Lin; Kouji Izumi; Qi Jiang; Kuo-Pao Lai; Defeng Xu; Lei-Ya Fang; Tianjing Lu; Lei Li; Shujie Xia; Chawnshang Chang
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

5.  Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network.

Authors:  Opal Lin-Tsai; Peter E Clark; Nicole L Miller; Jay H Fowke; Omar Hameed; Simon W Hayward; Douglas W Strand
Journal:  Prostate       Date:  2014-02-05       Impact factor: 4.104

6.  Human prostatic urethra expresses vitamin D receptor and responds to vitamin D receptor ligation.

Authors:  P Comeglio; A K Chavalmane; B Fibbi; S Filippi; M Marchetta; M Marini; A Morelli; G Penna; L Vignozzi; G B Vannelli; L Adorini; M Maggi
Journal:  J Endocrinol Invest       Date:  2010-04-12       Impact factor: 4.256

7.  Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.

Authors:  May Khalili; Laura N Mutton; Bora Gurel; Jessica L Hicks; Angelo M De Marzo; Charles J Bieberich
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

8.  Effects of dutasteride in a rat model of chemically induced prostatic inflammation-Potential role of estrogen receptor β.

Authors:  Shinsuke Mizoguchi; Kenichi Mori; Toshitaka Shin; Zhou Wang; Donald B DeFranco; Naoki Yoshimura; Hiromitsu Mimata
Journal:  Prostate       Date:  2020-09-17       Impact factor: 4.104

9.  A signaling network in phenylephrine-induced benign prostatic hyperplasia.

Authors:  Jayoung Kim; Yutaka Yanagihara; Tadahiko Kikugawa; Mihee Ji; Nozomu Tanji; Yokoyama Masayoshi; Michael R Freeman
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

Review 10.  Diabetes and benign prostatic hyperplasia: emerging clinical connections.

Authors:  Aruna V Sarma; J Kellogg Parsons
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.